HCG Hospitals adopts AI-driven smart digital scanning technology to improve cancer patient care

HealthCare Global Enterprises Ltd (HCG) on Monday announced that it has deployed Sigtuple's AI100 making HCG the first hospital chain to equip the Hematopathology labs across its network with AI-powered screening solutions for cancer detection and disease management. According to the company's press statement, SigTuple's AI100 is the premier solution for AI-assisted digital hematopathology. It is also the only digital hematopathology solution available that is economical and robust enough for wide-scale adoption, it claimed. "As manual microscopy is still the standard in diagnosing several critical disorders like cancers, infections, etc., in the absence of a pathologist at site in laboratories outside urban areas, these samples need to be shipped to central reference laboratories for review. Apart from the logistic challenges and associated delays in turnaround times, there is also limited expertise available for providing high quality diagnostics at remote locations," it stated.